Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort
- PMID: 25401375
- PMCID: PMC4652650
- DOI: 10.1001/jamainternmed.2014.6288
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort
References
-
- Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Journal of the American College of Cardiology. 2013 doi:10.1016/j.jacc.2013.11.002. - PubMed
-
- National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143–421. - PubMed
-
- Pencina MJ, Navar-Boggan AM, D'Agostino RB, Sr, et al. Application of New Cholesterol Guidelines to a Population-Based Sample. N Engl J Med. 2014 Mar 19; [Epub ahead of print] - PubMed
-
- Pasternak RC, Smith SC, Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, for the American College of Cardiology American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106:1024–1028. - PubMed
-
- ARIC Investigators The atherosclerosis risk in the communities (ARIC) study: design and objectives. Am J Epidemiol. 1989;129:687–702. - PubMed